Professor Mamas A. Mamas

Keele Cardiovascular Research Group, Centre for Prognosis Research Keele University Stoke-on-Trent, Department of Cardiology, Royal Stoke Hospital University Hospital North Staffordshire

Mamas A. Mamas is Director for the Centre for Prognosis Research at Institute of Primary Care and Health Sciences, Professor of Interventional Cardiology at Keele University, Honorary Consultant Interventional Cardiologist at Royal Stoke Hospital and Honorary Professor of Population Health, University of Manchester, UK. At an international level, he is an Adjunct Professor of Research at Jefferson University, Philadelphia, USA, and a Visiting Professor at Case Western University, Heart & Vascular Center, MetroHealth Medical Center, USA.

Professor Mamas is a practicing interventional cardiologist with a special interest in intravascular imaging, undertaking complex high risk indicated PCI cases in one of the largest PCI centres in the UK (Royal Stoke Hospital). At the Centre for Prognosis Research, he leads an MDT of clinicians, data scientists and statisticians in cross- thematic cardiology research, utilising routinely collected electronic healthcare data. He has published >750 peer-reviewed papers in high-impact international cardiovascular journals using big data in populations with cardiovascular disease, focusing around real world AMI outcomes and CV epidemiology with a particular focus around patients with cancer. He was recently voted as one of the top 100 health pioneers in the UK by the #MadeAtUni campaign based on his work.

He is in the 99 th percentile for peer reviewers on Publons, regularly reviewing for high- impact journals such as NEJM, Circulation, JACC, The Lancet and European Heart Journal.

He holds positions of responsibility with a number of societies, including being a board members of EAPCI, a member of the ESC WGs for CardioOncology and e-Cardiology and BCIS audit lead. He is a member of the ESC Quality Standards Diabetes working group, ACS and PCI groups and a reviewer for several ESC and AHA guidelines. He has contributed to the SCAI position statement on PCI activity in non-surgical centres, SCCT position statement around CardioOncology and acted as a reviewer for the 2022 AHA/ACC Chest Pain-AMI Data Standards. He is senior clinical editor of TCTMD, a leading resource for interventional cardiovascular news and education.